Condensed Statements of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Beginning balances at Jan. 31, 2013	$ (152,340)	$ 1,899	$ 8,418,685	$ (8,529,007)	$ (43,917)
Shares, Beginning balance at Jan. 31, 2013		1,898,727
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net loss	(20,521)			0	(20,521)
Ending balances at Apr. 30, 2013	$ (172,861)	$ 1,899	$ 8,418,685	$ (8,529,007)	$ (64,438)
Shares, Ending balance at Apr. 30, 2013		1,898,727